Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.
Products, services, technology
Trialize provides a comprehensive Clinical Trial Automation platform featuring eCOA, eConsent, ePRO, EDC, MDR, SCE, Data Warehouse, and Workflow automation capabilities. It can replace leading CTMS system or be implemented module-by-module. Additionally, we offer bespoke AI development services.
Harnessing Trialize's cutting-edge automation in their clinical trials, Pharma, Biotech, and CROs can achieve substantial cost savings and expedite their time-to-market, unlocking unprecedented efficiency and productivity.
Trialize revolutionizes clinical trials with AI and robotic process automation, slashing research time and R&D expenses. This acceleration drives the emergence of new therapies, paving the way for more cures and better health outcomes.
Recent PTSD study in Ukraine witnessed Trialize outperforming leading CTMS systems, slashing labor requirements by 75% and boosting team efficiency by an impressive 73%. Our solution sets a new standard in trial efficiency.
Trialize boasts a stellar team of AI, software engineering, data standards, and UX design professionals. We're set to elevate our product marketing and operations with equally unparalleled expertise. Excellence in every expansion!
Swiss biotech can boost Trialize via partnerships with leading biopharma firms, collaborations with top-tier research institutions, regulatory guidance, access to funding, biotech networking events, and a diverse talent pool.
Key decision-makers for implementing Trialize may include Clinical Operations Directors, Heads of Clinical Data Management, CIOs, Heads of R&D, CEOs, CFOs, Regulatory Affairs Directors, and Procurement Managers.